Probiotics are sometimes suggested to support gut health, though evidence for their efficacy in managing GLP-1 receptor agonist-related side effects is limited
In the SURPASS-2 trial, tirzepatide demonstrated greater HbA1c reduction and weight loss compared to semaglutide 1 mg in type 2 diabetes
Injection technique for semaglutide Good technique is not optional
Keeping a journal or using digital tools can aid in tracking progress and identifying any concerns promptly
Suggestive but not conclusive evidence preclinical studies, small clinical trials, and anecdotal reports has found that GLP-1 agonists might improve memory, reduce rates of dementia, and more, suggesting they may be effective Alzheimers treatments
MACE, major adverse cardiovascular event(s)